Simulations Plus
Simulations Plus

Simulations Plus

Life Sciences Tools & Services
WebsiteInvestor RelationsSEC
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

$374.2M

Market Cap • 10/2/2026

1996

(30 years)

Founded

1997

(29 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

2,7

P/S

4,6

P/EBITDA

21,9

P/OCF

15

P/FCF

15,2

P/E

46,3

BVPS

6,9

EPS

0,4

Market Cap

Market Cap

374,2M

EV

324,7M

EV/Revenue

4

EV/EBITDA

19

EV/EBIT

28,2

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-0,2%

Total Yield

-0,2%

Dividend Yield 5Y

0,2%

Payout

0%

Retained Earnings

-25,6M

Profitability

Gross Margin

63,4%

EBITDA Margin

20,9%

EBIT Margin

14%

Net Margin

9,9%

D&A/EBITDA

0%

R&D/Revenue

14,1%

Capex/Revenue

0,5%

Capex/D&A

7,2%

Capex/OCF

1,6%

SBC/OCF

25,7%

% PPE

7,9%

% Goodwill

28,6%

ROE

6,2%

ROIC

8%

Growth

CAGR Revenue 5Y

12,2%

CAGR Op. Income 5Y

-2,8%

CAGR Net Income 5Y

-7%

CAGR EPS 5Y

-6,5%

CAGR OCF 5Y

9,6%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

5,5

Quick Ratio

5

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium